Burkina Faso vs Niger: Population requiring preventive chemotherapy for schistosomiasis
Burkina Faso
4.46 million
in 2024
Niger
5.10 million
in 2024
Burkina Faso rank
19th
Niger rank
16th
Population requiring preventive chemotherapy for schistosomiasis over time
- Burkina Faso
- Niger
How they compare
Niger currently reports 5.10 million against 4.46 million in Burkina Faso, a difference of 635,800.
That makes Niger's figure about 1.1 times Burkina Faso's.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Niger ahead.
Burkina Faso ranks 19th and Niger ranks 16th of 52 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.88 million | 5.02 million | 1.14 million | Niger |
| 2020s | 3.48 million | 8.69 million | 5.21 million | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Burkina Faso or Niger?
- Niger, at 5.10 million against 4.46 million in Burkina Faso as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Burkina Faso and Niger?
- 635,800, with Niger ahead.
- How many years of comparable data are there for Burkina Faso and Niger?
- 15 years are reported by both, from 2010 to 2024.
- How do Burkina Faso and Niger rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Burkina Faso ranks 19th and Niger ranks 16th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.